>
Switch to:

Biohaven Pharmaceutical Holding Co Total Inventories

: $64.1 Mil (As of Jun. 2021)
View and export this data going back to 2017. Start your Free Trial

Biohaven Pharmaceutical Holding Co's total inventories for the quarter that ended in Jun. 2021 was $64.1 Mil. Biohaven Pharmaceutical Holding Co's average total inventories from the quarter that ended in Mar. 2021 to the quarter that ended in Jun. 2021 was $61.2 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Biohaven Pharmaceutical Holding Co's Net-Net Working Capital per share for the quarter that ended in Jun. 2021 was $-11.88.

Inventory can be measured by days sales of inventory (DSI). Biohaven Pharmaceutical Holding Co's days sales of inventory (DSI) for the three months ended in Jun. 2021 was 60.09.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Biohaven Pharmaceutical Holding Co's Days Inventory for the three months ended in Jun. 2021 was 322.04.

Inventory Turnover measures how fast the company turns over its inventory within a year. Biohaven Pharmaceutical Holding Co's Inventory Turnover for the quarter that ended in Jun. 2021 was 0.28.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Biohaven Pharmaceutical Holding Co's Inventory-to-Revenue for the quarter that ended in Jun. 2021 was 0.66.


Biohaven Pharmaceutical Holding Co Total Inventories Historical Data

The historical data trend for Biohaven Pharmaceutical Holding Co's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biohaven Pharmaceutical Holding Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Total Inventories
Premium Member Only - - - - 39.56

Biohaven Pharmaceutical Holding Co Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Total Inventories Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.97 20.13 39.56 58.33 64.06

Biohaven Pharmaceutical Holding Co Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Biohaven Pharmaceutical Holding Co  (NYSE:BHVN) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Biohaven Pharmaceutical Holding Co's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2021 is

Net-Net Working Capital Per Share (Q: Jun. 2021 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(366.107+0.75 * 168.637+0.5 * 64.058-1302.489
-0--2.719)/65.2405
=-11.88

2. Inventory can be measured by Days Sales of Inventory (DSI).

Biohaven Pharmaceutical Holding Co's Days Sales of Inventory for the three months ended in Jun. 2021 is

Days Sales of Inventory (DSI)
=Total Inventories (Q: Jun. 2021 )/Revenue (Q: Jun. 2021 )*Days in Period
=61.1935/92.933*365 / 4
=60.09

3. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Biohaven Pharmaceutical Holding Co's Days Inventory for the three months ended in Jun. 2021 is calculated as:

Days Inventory=Total Inventories (Q: Jun. 2021 )/Cost of Goods Sold (Q: Jun. 2021 )*Days in Period
=61.1935/17.339*365 / 4
=322.04

4. Inventory Turnover measures how fast the company turns over its inventory within a year.

Biohaven Pharmaceutical Holding Co's Inventory Turnover for the quarter that ended in Jun. 2021 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jun. 2021 ) / Total Inventories (Q: Jun. 2021 )
=17.339 / 61.1935
=0.28

5. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Biohaven Pharmaceutical Holding Co's Inventory to Revenue for the quarter that ended in Jun. 2021 is calculated as

Inventory-to-Revenue=Total Inventories (Q: Jun. 2021 ) / Revenue (Q: Jun. 2021 )
=61.1935 / 92.933
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Biohaven Pharmaceutical Holding Co Total Inventories Related Terms

Thank you for viewing the detailed overview of Biohaven Pharmaceutical Holding Co's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Biohaven Pharmaceutical Holding Co Business Description

Biohaven Pharmaceutical Holding Co logo
Industry
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Traded in Other Exchanges
Address
C/o Biohaven Pharmaceuticals, Inc., 215 Church Street, New Haven, CT, USA, 06510
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others.
Executives
Bailey Gregory director 4 A CHESHAM STREET LONDON X0 SW1X8DT
Gentile Kimberly officer: SVP, Clinical Operations C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Childs John W director 111 HUNTINGTON AVENUE SUITE 2900 BOSTON MA 02199
Berman Robert officer: Special Projects & Med Ovrsght C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Doogan Declan director C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Stock Elyse officer: Chief Medical Officer 215 CHURCH STREET NEW HAVEN CT 06510
Engelhart James officer: Chief Financial Officer C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Tilton John officer: Chief Commercial Officer C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Hugin Robert J director C/O THE MEDICINES CO 8 CAMPUS DR PARSIPPANY NJ 07054
Heffernan Michael Thomas director C/O CORNERSTONE THERAPEUTICS INC. 1255 CRESCENT GREEN DRIVE, SUITE 250 CARY NC 27518
Gregory Julia P director 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Aguiar Eric director 888 7TH AVENUE 12TH FLOOR NEW YORK NY 10106
Coric Vlad director, officer: Chief Executive Officer C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Jones William A Jr officer: CCO-Migraine & Common Disease NITROMED, INC. 125 SPRING STREET LEXINGTON MA 02421
Conway Charles officer: Chief Scientific Officer C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510

Biohaven Pharmaceutical Holding Co Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)